New York State Dormitory Authority/New York State's 4201 School Fac Program Rev Bonds Rated A Nov 00

  • ID: 1954048
  • November 2000
  • Region: New York
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's CreditWire) Nov. 15, 2000--Standard & Poor's today assigned its single-'A' rating to New York State Dormitory Authority's $13.85 million 4201 school facility program revenue bonds series 2000 dated Nov. 1, 2000, due July 1, 2020, issued for New York State. The bonds are scheduled to sell on Nov. 16, 2000. In addition, Standard & Poor's affirmed its single-'A' rating on the authority's outstanding 4201 school facility program revenue bonds, issued for the state. The outlook is stable. The rating reflects: -- New York State's general creditworthiness as lessee; -- The payment of debt service subject to annual state appropriation; -- Additional credit security provided by the deposit of the state appropriation on behalf of the...

Companies mentioned in this report are:
- Dorm Auth of the St of New York

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Dorm Auth of the St of New York

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.